lobbying_activities: 629891

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
629891	39edbb1c-6913-43f8-a55e-ab0d990fa461	Q2	POLICY DIRECTIONS INC.	31747	RECKITT BENCKISER LLC (FORMERLY KNOWN AS RECKITT BENCKISER)	2008	second_quarter	LAW	S. 2274, Dextromethorphan Abuse Reduction Act of 2007, proposed scheduling of unfinished Dextromethophan as a Schedule V product under the Controlled Substances Act and mandates restriction for the sale of retail products which contain Dextromethorphan. S. 2237, Crime Control and Prevention Act of 2007, Subtitle B containing the same provisions as in the Dextromethorphan Abuse Reduction Act of 2007.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2008-07-16T10:47:01-04:00